Natural history of vestibular schwannomas and hearing loss in NF2 patients

被引:14
|
作者
Peyre, M. [1 ,3 ]
Bernardeschi, D. [2 ,3 ]
Sterkers, O. [3 ]
Kalamarides, M. [1 ,3 ]
机构
[1] Hop La Pitie Salpetriere, AP HP, Serv Neurochirurg, Paris, France
[2] Hop La Pitie Salpetriere, AP HP, Serv Otol Otoneurochirurg & Chirurg Cervifaciale, F-75013 Paris, France
[3] Univ Pierre & Marie Curie Paris VI, F-75013 Paris, France
关键词
Neurofibromatosis type 2; Vestibular schwannoma; Conservative treatment; Natural history; Tumor growth; NEUROFIBROMATOSIS TYPE-2; TUMOR-CONTROL; GROWTH-RATES; PRESERVATION; RADIOSURGERY; MANAGEMENT;
D O I
10.1016/j.neuchi.2015.03.012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Context and objective. - Bilateral vestibular schwannomas are the hallmark of neurofibromatosis 2 (NF2), occurring in 95% of patients. These tumors are associated with significant morbidity due to hearing loss, tinnitus, imbalance and facial weakness. As radiosurgery and chemotherapy have been recently introduced in the treatment armamentarium in addition to surgery, a thorough evaluation of vestibular schwannoma natural history is mandatory to determine the role and timing of each treatment modality. Methods. - An exhaustive review of the literature was performed using the PubMed database concerning the natural history of tumor growth and hearing loss in NF2 patients with vestibular schwannomas. Results. - Although some aspects of vestibular schwannoma natural history remain uncertain (pattern of tumor growth, mean tumor growth rate), factors influencing growth such as age at presentation and paracrine factors are well established. Studies focusing on the natural history of hearing have highlighted different patterns of hearing loss and the possible role of intralabyrinthine tumors. The polyclonality of vestibular schwannomas in NF2 was recently unveiled, giving a new perspective to their growth mechanisms. Conclusion. - An uniform evaluation of tumor growth using volumetric evaluation and hearing with standard classifications will ensure the use of common endpoints and should improve the quality of clinical trials as well as foster comparison among studies while ensuring more consistency in decision-making. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:342 / 347
页数:6
相关论文
共 50 条
  • [1] Results of Bevacizumab Therapy on Hearing Loss Associated with Vestibular Schwannomas in NF2: Three Patients
    Termsarasab, Pichet
    Rogers, Lisa
    Megerian, Cliff
    Bambakidis, Nicholas
    [J]. NEUROLOGY, 2012, 78
  • [2] Bevacizumab induces regression of vestibular schwannomas leading to improved hearing in NF2 patients
    Mautner, V.
    Nguyen, R.
    Friedrich, R.
    Kutta, H.
    Fuensterer, C.
    Hagel, C.
    Panse, J.
    [J]. ONKOLOGIE, 2010, 33 : 57 - 57
  • [3] Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas
    Hadfield, K. D.
    Smith, M. J.
    Urquhart, J. E.
    Wallace, A. J.
    Bowers, N. L.
    King, A. T.
    Rutherford, S. A.
    Trump, D.
    Newman, W. G.
    Evans, D. G.
    [J]. ONCOGENE, 2010, 29 (47) : 6216 - 6221
  • [4] Bilateral vestibular schwannomas in older patients: NF2 or chance?
    Evans, D. G.
    Freeman, S.
    Gokhale, C.
    Wallace, A.
    Lloyd, S. K.
    Axon, P.
    Ward, C. L.
    Rutherford, S.
    King, A.
    Huson, S. M.
    Ramsden, R. T.
    [J]. JOURNAL OF MEDICAL GENETICS, 2015, 52 (06) : 422 - 424
  • [5] Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas
    K D Hadfield
    M J Smith
    J E Urquhart
    A J Wallace
    N L Bowers
    A T King
    S A Rutherford
    D Trump
    W G Newman
    D G Evans
    [J]. Oncogene, 2010, 29 : 6216 - 6221
  • [6] Evaluation of neurofibromatosis 2 (NF2) clinical diagnostic criteria in NF2 patients without bilateral vestibular schwannomas.
    Baser, ME
    Friedman, JM
    Wallace, A
    Ramsden, RT
    Evans, DGR
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 56 - 56
  • [7] Vestibular schwannomas in NF2: Prognostic factors and results of treatments
    Saito, K
    Otsuka, G
    Yoshida, J
    [J]. THIRD INTERNATIONAL CONFERENCE ON ACOUSTIC NEURINOMA AND OTHER CPA TUMORS, 1999, : 721 - 725
  • [8] Novel alternatively spliced NF2 transcripts in vestibular schwannomas
    Akhmametyeva, EM
    Yao, SN
    Wu, Y
    Welling, DB
    Chang, LS
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 272A - 272A
  • [9] NF2 GENE-MUTATIONS IN MENINGIOMAS AND VESTIBULAR SCHWANNOMAS
    ZWARTHOFF, EC
    BIANCHI, AB
    GROEN, NA
    KLEY, N
    SEIZINGER, BR
    HAGEMEIJER, A
    VANDRUNEN, E
    BOOTSMA, D
    KOPER, JW
    AVEZAAT, CJJ
    DEPREZ, RHL
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 194 - 194
  • [10] Molecular genetic analysis of the NF2 gene in young patients with unilateral vestibular schwannomas
    Mohyuddin, A
    Neary, WJ
    Wallace, A
    Wu, CL
    Purcell, S
    Reid, H
    Ramsden, RT
    Read, A
    Black, G
    Evans, DGR
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (05) : 315 - 322